Two biological isolator facilities have been established to facilitate clinical development of human cell-based therapies. Established under the auspices of the Victorian Consortium for Cell-based Therapies (VCCT), the isolators provide a complete barrier from environmental and operator-borne contamination and are therefore ideally suited for aseptic processing.
Established through a $2 million grant from the Australian Cancer Research Foundation, the Centre includes a Mediso Nanoscan PET/MRI Imaging Platform, a Mediso Nanoscan SPECT/CT Imaging Platform and an IVIS Spectrum Bioluminescent and Fluorescence Imaging Unit for medical research and preclinical investigations.
The MPEF is a unique facility that can produce small to large amounts of high quality recombinant proteins and antibodies for use in medical research.
The VPTN provides a resource to local research community to present their research core facilities, instrumentation and services under a comprehensive website. Its a scientific services business directory.
VLSCI is the biggest computation facility devoted to life sciences in the world, where researchers can access high-end compute resources and a range of experts to assist them - from research design through to data management and interpretation.
The Victorian Cancer Biobank is a not-for-profit consortium of tissue banks, supported by the Victorian Government through the Victorian Cancer Agency. Our purpose is to provide high quality, ethically obtained biospecimens to support research that will lead to improvements in cancer diagnosis and treatment.
The Florey Statistics and Decision Analysis academic platform provides expertise in the data, quantitative, and statistical aspects of basic science, clinical, imaging, and health services research carried out at Florey Institute of Neuroscience and Mental Health, Melbourne Brain Centre, as well as to external clients and collaborators.
RMIT Flow Cytometry at the Health Innovations Research Precinct
The LIMS Microscopy and Imaging Facility offers academic and industry users access to $2m of sophisticated light microscopy equipment for biological imaging. We train and support researchers to independently operate instruments on a fee for use basis.
The Mass Spectrometry & Proteomics Facility provides comprehensive proteomics and quantitative proteomics capabilities for the discovery and quantitation of proteins at extremely high sensitivity.
The Imaging Division of the Brain Research Institute facilitates co-ordinates and assists in research in the neurosciences using advanced imaging techniques
The HTCS Facility houses a Lead Discovery library currently containing ~200,000 compounds and robotics platforms to screen these small molecule chemical entities against biological targets of interest for drug discovery or for chemical biology outcomes
Understanding the physics of fluid flow in micro-geometries and its manipulation plus for the development of Lab-on-a-chip devices that allow high sensitivity (single molecule level) of biological/chemical detection
Specific and sensitive drug and hormone quantitation in biological matrices.
The CDCO is a world-class collaborative research centre that provides ADME lead candidate optimisation expertise and infrastructure to support emerging drug discovery programs within biotechnology and pharmaceutical companies and not-for-profit research institutes.